DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactOrders & Deals

Paradeep Phosphates Limited — Acquisition (including agreement to acquire)-XBRL

NSE 1 hr ago·5 Aug 2026, 12:47 pm

Paradeep Phosphates

Paradeep Phosphates Limited has announced an acquisition, which involves signing an agreement to buy another company. This strategic move signals the company's intent to expand its business operations and market reach.

For investors, this development is significant as it could enhance Paradeep Phosphates' future revenue streams and operational capabilities. However, the success of such a deal depends on effective integration and execution.

Investors should watch for further details on the target company, the deal's financial terms, and the timeline for completion. These factors will determine the long-term impact on the company's performance and stock value.